LENZ THERAPEUTICS INC reports a Return on Equity (ROE) of -44.22%.

What is LENZ's dividend yield?

LENZ THERAPEUTICS INC offers a dividend yield of 0.00%.

What is LENZ's Quality Score?

Our AI rates LENZ's overall financial quality at 8 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy LENZ?

Our AI Timing Score for LENZ is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does LENZ belong to?

LENZ THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

LENZ (NASDAQ) Stock Analysis | LENZ THERAPEUTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

LENZ AI Analysis Summary

Our AI summary for LENZ: LENZ THERAPEUTICS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -44.22%, a dividend yield of 0.00%. Its financial Quality Score stands at 8/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LENZ

LENZ THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 5.30

-0.46 (-7.99%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-44.2%

ROE

-40.0%

ROA

0.00%

Div Yield

LENZ THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 5.30 Price -0.46 (-7.99%) Day Change	NEWS SCORE: 91

LENZ, the overall quality is not good ( Quality = 8) and the timing to buy is ...(Sign In to See)...

Loading chart...

8 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	5.30
PBV / Sector	0.73 / 5.20 GREAT
Earning Per Share	-3.20

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	5.80 M GREAT
Average 1W Daily Value	4.40 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-519.30 / 98.71
NPM Average (%) / Sector	-340.54 / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-39.99 / 27.02
ROA Average (%) / Sector	-42.48 / -368.17
ROA Change Average (%) / Sector	80.03 / 5,404.12 GREAT
ROE (%) / Sector	-44.22 / 3.47
ROE Average (%) / Sector	4.54 / 6.51
ROE Change Average (%) / Sector	1.98 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:06
Symbol	LENZ
Name	LENZ THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	31.35 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	180.60 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075

Phone: 858 925 7000

Website: https://www.lenz-tx.com

Employees: 152

Sector: Healthcare >> Biotechnology

Description: LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.